Physician
General Surgery
Dr. Mark A. Jensen, MD
|
|
Give Review
Mark Jensen is an expert in the field of General Surgery. He went to medical school at University of Minnesota Medical School. University of Minnesota Medical School is ranked 40 in research and 10 in primary care medicine Doctor Mark A. Jensen, MD is a published physician. He has 52 papers published. The most current publication "All-trans retinoic acid potentiates the ability of interferon beta-1b to augment suppressor cell function in multiple sclerosis." He is registered with Medicare and accepts Medicare payments.
Publications
- Deep Third Variable Sequencing for HIV Type 1 Tropism in Treatment-Naive Patients: A Reanalysis of the MERIT Trial of Maraviroc.
- Rapid Immune Responses to a Botulinum Neurotoxin Hc Subunit Vaccine Through In Vivo Targeting to Antigen Presenting Cells.
- Deep sequencing to infer HIV-1 co-receptor usage: application to three clinical trials of maraviroc in treatment-experienced patients.
- Improved detection of CXCR4-using HIV by V3 genotyping: application of population-based and "deep" sequencing to plasma RNA and proviral DNA.
- A comparison of interpretation by three different HIV type 1 genotypic drug resistance algorithms using sequences from non-clade B HIV type 1 strains.
- Targeting of myelin protein zero in a spontaneous autoimmune polyneuropathy.
- Predicting Disease outcomes in the clinic.
- HIV type 1 superinfection with a dual-tropic virus and rapid progression to AIDS: a case report.
- Reconstruction and function of ancestral center-of-tree human immunodeficiency virus type 1 proteins.
- Coping with viral diversity in HIV vaccine design.
- HIV-specific probabilistic models of protein evolution.
- A reliable phenotype predictor for human immunodeficiency virus type 1 subtype C based on envelope V3 sequences.
- Modeling the role of bacteriophage in the control of cholera outbreaks.
- Changes in human immunodeficiency virus type 1 fitness and genetic diversity during Disease progression.
- Molecular clock-like evolution of human immunodeficiency virus type 1.
- Influence of random genetic drift on human immunodeficiency virus type 1 env evolution during chronic infection.
- Improved coreceptor usage prediction and genotypic monitoring of R5-to-X4 transition by motif analysis of human immunodeficiency virus type 1 env V3 loop sequences.
- Evolutionary indicators of human immunodeficiency virus type 1 reservoirs and compartments.
- Consensus and ancestral state HIV vaccines.
- Genetic characterization of rebounding human immunodeficiency virus type 1 in plasma during multiple interruptions of highly active antiretroviral therapy.
- Patterns of genetic variation at a chromosome 4 locus of Drosophila melanogaster and D. simulans.
- Anti-S-nitrosocysteine antibodies are a predictive marker for demyelination in experimental autoimmune encephalomyelitis: implications for multiple sclerosis.
- Eicosenoids Modify Experimental Allergic Encephalomyelitis.
- BIO::Phylo-phyloinformatic analysis using perl.
- A novel Fc gamma receptor ligand augments humoral responses by targeting antigen to Fc gamma receptors.
- HIV-1 with predicted CXCR4 genotype identified in clade C from India.
- Sources of variation in ancestral sequence reconstruction for HIV-1 envelope genes.
- Immunoglobulin-like transcript 3, an inhibitor of T cell activation, is reduced on blood monocytes during multiple sclerosis relapses and is induced by interferon beta...
- Clinical and immunological impact of HIV envelope V3 sequence variation after starting initial triple antiretroviral therapy.
- Dual HIV-1 infection associated with rapid Disease progression.
- Potential impact of recombination on sitewise approaches for detecting positive natural selection.
- Predicting HIV-1 coreceptor usage with sequence analysis.
- Evolutionary dynamics of HIV-1 and the control of AIDS.
- Cytokine secretion by deltagamma and alphabeta T cells in monophasic experimental autoimmune encephalomyelitis.
- A reduction in serum glucocorticoids provokes experimental allergic encephalomyelitis: implications for treatment of inflammatory brain Disease.
- All-trans retinoic acid potentiates the ability of interferon beta-1b to augment suppressor cell function in multiple sclerosis.
- Interferon-gamma-secreting cells in multiple sclerosis patients treated with interferon beta-1b.
- Interferon gamma- and interleukin-4-secreting cells in multiple sclerosis.
- Molecular population genetics and evolution of a prion-like protein in Saccharomyces cerevisiae.
- Global inhibition of IL-2 and IFN-gamma secreting T cells precedes recovery from acute monophasic experimental autoimmune encephalomyelitis.
- Design and expression of polymeric immunoglobulin fusion proteins: a strategy for targeting low-affinity Fcgamma receptors.
- Mechanisms of action of interferon-beta in multiple sclerosis.
- Interferon beta decreases T cell activation and interferon gamma production in multiple sclerosis.
- Prostaglandins and inhibitors of arachidonate metabolism suppress experimental allergic encephalomyelitis.
- Preferential increase of IL-2R+ CD4+ T cells and CD45RB- CD4+ T cells in the central nervous system in experimental allergic encephalomyelitis.
- Astrocyte cytolysis by MHC class II-specific mouse T cell clones.
- Interferon beta augments suppressor cell function in multiple sclerosis.
- Contrasting effects of alpha, beta, and gamma interferons on nonspecific suppressor function in multiple sclerosis.
- Central nervous system cytokine mRNA expression following Theiler''s murine encephalomyelitis virus infection.
- Protein interactions with the glucose transporter binding protein GLUT1CBP that provide a link between GLUT1 and the cytoskeleton.
- A system for rapid DNA sequencing with fluorescent chain-terminating dideoxynucleotides.
Schools
University of Mn Med Sch
La Co Harbor UCLA Med Center
St Elizabeth Health Center
Procedures Preformed
- Appendectomy, Open
- Colectomy
- Excision of Breast Tumor
- Excision, Shaving, or Destruction of Skin and Subcutaneous Tissue (incl. Mohs Micrographic Surgery), Tissue Transfer
- View All
Conditions Treated
- Abdominal Pain
- Appendicitis
- Atelectasis
- Breast Cancer
- View All
Doctors Specialties
- General Surgery
Accepted Insurances
Education
-
Harbor - UCLA Medical Center -
University of Minnesota Medical School
Drug Facts
| NPI NUMBER | 1093715062 | |
| NPPES Provider LastName | JENSEN | |
| NPPES Provider FirstName | MARK | |
| NPPES Provider ZIPCode | 465803212 | |
| NPPES Provider State | IN | |
| Specialty Description | General Surgery | |
| Total Claim Count | 117.0 | |
| Distinct Opioid Count | 1.0 | |
| Opioid Claim Count | 19.0 | |
| Percent Opioid Claims | 16.24 |
Helpful Reviews
Medicare Facts
| National Provider Identifier [NPI] | 1093715062 |
| Last Name Of The Provider | JENSEN |
| First Name Of The Provider | MARK |
| View All |
Similar Doctors
|
|
Dr. Paul T. Haney, MD
 This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Patrick B. Ilada, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. John M. Musgrave, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Adria L. Ford, DO
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Kishan T. Kishan, MD
This Doctor is OpenDoctor Recommended.
|
|
|
Dr. Corey F. Graham, MD
This Doctor is OpenDoctor Recommended.
|